Akero Therapeutics Inc buy Citigroup Inc.
Start price
18.11.24
/
50%
€27.54
Target price
18.11.25
€61.49
Performance (%)
69.39%
End price
19.11.25
€46.65
Summary
This prediction ended on 19.11.25 with a price of €46.65. The BUY prediction by Citigroup_Inc_ for Akero Therapeutics Inc saw massive gains of 69.39%. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -0,87 % | 5,32 % | 6,86 % |
| iShares Nasdaq 100 | -0,38 % | 1,98 % | 25,70 % |
| iShares Nikkei 225® | -1,68 % | 1,95 % | 41,44 % |
| iShares S&P 500 | -0,65 % | 2,07 % | 21,40 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $65.00 price target on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€35.77
13.05.25
13.05.25
€70.22
13.05.26
13.05.26
31.31%
14.05.26
14.05.26
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€53.14
28.01.25
28.01.25
€76.71
28.01.26
28.01.26
-11.61%
29.01.26
29.01.26